These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34638192)

  • 1. [The relationship of resilience with cognitive function in patients with first-episode schizophrenia].
    Wu JY; Xia XW; Liu T; Zhao JS; Dai JM; Li ZN; Chen C; Qiu Y; Han ZL; Wei QL
    Zhonghua Yi Xue Za Zhi; 2021 Oct; 101(37):3006-3011. PubMed ID: 34638192
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
    Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain gray matter volume alterations and cognitive function in first-episode childhood-and adolescence-onset schizophrenia].
    Gao ZT; Li YL; Guo SQ; Xia YH
    Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(45):3581-3586. PubMed ID: 31826575
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the correlation between gut microbiota and folic acid in first-episode schizophrenia].
    Miao Y; Li X; Yuan XX; Zhang LY; Pang LJ; Zhang XY; Wang SY; Song XQ
    Zhonghua Yi Xue Za Zhi; 2021 Oct; 101(37):3012-3017. PubMed ID: 34638193
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of cognitive impairment on social function and quality of life in chronic schizophrenia].
    Chen SY; Wen F; Zhao CB; Zhang DM; Wu XL
    Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(5):351-356. PubMed ID: 32074778
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor as a potential novel biomarker for cognitive function in patients with first-episode schizophrenia.
    Yu JJ; Zhao Q; Li HN; Song JQ; Chen DC
    Aust N Z J Psychiatry; 2022 Mar; 56(3):292-300. PubMed ID: 33985351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors.
    Chen S; Liu Y; Liu D; Zhang G; Wu X
    Schizophr Res Cogn; 2021 Jun; 24():100195. PubMed ID: 33718008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of the peripheral serum complement protein levels and cognitive function in first-episode drug-naive patients with schizophrenia].
    Xia XW; Li LJ; Chen ZC; Qiu Y; Zhao JS; Wu JY; Liu T; Dai JM; Li ZN; Chen C; Han ZL; Wei QL
    Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(39):3081-3085. PubMed ID: 33105959
    [No Abstract]   [Full Text] [Related]  

  • 10. Cognitive Deficits and Clinical Symptoms with Hippocampal Subfields in First-Episode and Never-Treated Patients with Schizophrenia.
    Xiu MH; Lang X; Chen DC; Cao B; Kosten TR; Cho RY; Shi H; Wei CW; Wu AS; Zhang XY
    Cereb Cortex; 2021 Jan; 31(1):89-96. PubMed ID: 32901269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
    Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor analyzing the Norwegian MATRICS Consensus Cognitive Battery.
    Mohn C; Lystad JU; Ueland T; Falkum E; Rund BR
    Psychiatry Clin Neurosci; 2017 May; 71(5):336-345. PubMed ID: 28182301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
    Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment.
    Zhang H; Wang Y; Hu Y; Zhu Y; Zhang T; Wang J; Ma K; Shi C; Yu X; Li C
    Gen Psychiatr; 2019; 32(3):e100043. PubMed ID: 31423473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
    Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are negative symptoms really related to cognition in schizophrenia?
    Bagney A; Dompablo M; Santabárbara J; Moreno-Ortega M; Lobo A; Jimenez-Arriero MA; Palomo T; Rodriguez-Jimenez R
    Psychiatry Res; 2015 Dec; 230(2):377-82. PubMed ID: 26454405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of oxidative stress on cognitive impairment in first episode schizophrenia].
    Wang YP; Zhang PF; Yuan XX; Liu YF; Li HH; Tao Q; Li X; Pang LJ; Song XQ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):9-13. PubMed ID: 30641657
    [No Abstract]   [Full Text] [Related]  

  • 20. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
    Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
    Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.